Michel Darnaud

CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up studio MD Start and is funded by renowned investors including Bpifrance, Exor Ventures, EIC Fund, Financière Arbevel, M&L Healthcare, Novo Holdings, Seventure Partners, Sofinnova Partners, Ysios Capital and Vlerick Group. The company has secured over €80 million in equity and employs over seventy people.

Emeric Lepoutre & Partners had been created in 2015 by Emeric Lepoutre (formerly Head of Heidrick & Struggles France and of Spencer Stuart France, then Founder of the Eric Salmon Board Practice - for over 18 years). Emeric, his Partners and team who came along with him focus on : - Executive Search (top level ExCom members), - Board Searches (french and international), - Board Assessments - Advice in Corporate Governance. The Firm advice CAC 40 groups and international companies in identifying talents for executive positions (CEOs, ExCom members and Functional heads) for all kind of industries (Finance, Industrial, Services, Consumer Goods, Retail, Technology, Life Science...).

Agile Capital Markets delivers tailored financial services for healthcare companies and investors. We focus on four business lines: Fundraising, Mergers & Acquisitions, Licensing, and Investor Services. We empower biotech, medtech, digital health, pharmaceutical companies, CROs/CDMOs, other healthcare service companies and investment funds to thrive by facilitating impactful transactions and unlocking growth opportunities, all backed by our deep expertise in healthcare. Agile Capital Markets in a nutshell: - €1.2Bn+ transactions secured - 18 transactions in the last 24 months - size of transactions from €15M to €150M+

Gimv is a European investment company with more than 40 years​ experience in private equity. Listed on Euronext Brussels, Gimv currently has EUR 1.5 billion of assets under management. The portfolio contains around 60 portfolio companies, with a combined turnover of EUR 3.7 billion and more than 20,000 employees. As a recognized market leader in selected investment platforms, Gimv identifies entrepreneurial and innovative companies with high-growth potential and supports them in their transformation into market leaders. Gimv’s five investment platforms are: Consumer, Healthcare, Life Sciences, Smart Industries and Sustainable Cities. Each of these platforms works with a skilled and dedicated team across Gimv’s home markets of the Benelux, France and Germany and can count on an extended international network of experts. We are a strategic partner for ambitious companies wanting to grow into leaders in their sectors. We help them plan ways to speed up their expansion. We take a flexible approach based on our solid balance sheet, patient capital and long-term view. Hand-in-hand with growth companies, we are working on innovative solutions for tomorrow’s society. More information on Gimv can be found on www.gimv.com.

CorWave is a French company developing innovative cardiac assist devices. CorWave’s wave membrane pump is a breakthrough technology that differs from today’s commercially available left ventricular assist devices (LVADs) by its physiological operation, designed to mimic a pulse and blood flow rates similar to those of a healthy heart. Ultimately, CorWave’s membrane pump technology is expected to reduce the complications associated with current devices and improve the management of heart failure patients. A member of the French Tech 120, CorWave was founded in 2012 by start-up studio MD Start and is funded by renowned investors including Bpifrance, Exor Ventures, EIC Fund, Financière Arbevel, M&L Healthcare, Novo Holdings, Seventure Partners, Sofinnova Partners, Ysios Capital and Vlerick Group. The company has secured over €80 million in equity and employs over seventy people.